References
Luzzatto L, Gianfaldoni G, Notaro R (2011) Management of paroxysmal nocturnal haemoglobinuria: a personal view. Br J Haematol 153(6):709–720
Berzuini A, Montanelli F, Prati D (2010) Hemolytic anemia after eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 363(10):993–994
Hill A, Rother RP, Wang X, Morris SM Jr, Quinn-Senger K, Kelly R, Richards SJ, Bessler M, Bell L, Hillmen P, Gladwin MT (2010) Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 149(3):414–425
Risitano AM, Notaro R, Luzzatto L, Hill A, Kelly R, Hillmen P (2010) Paroxysmal nocturnal hemoglobinuria–hemolysis before and after eculizumab. N Engl J Med 363(23):2270–2272
Risitano AM, Notaro R, Marando L, Serio B, Ranaldi D, Seneca E, Ricci P, Alfinito F, Camera A, Gianfaldoni G, Amendola A, Boschetti C, Di Bona E, Fratellanza G, Barbano F, Rodeghiero F, Zanella A, Iori AP, Selleri C, Luzzatto L, Rotoli B (2009) Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood 113(17):4094–4100
Conflict of interest/disclosure
All authors declare no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tomita, A., Shirasugi, Y., Ito, T. et al. Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria. Ann Hematol 91, 1139–1141 (2012). https://doi.org/10.1007/s00277-011-1368-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-011-1368-z